Filter
1523
Text search:
pharmaceutical
guidelines
Featured
155
400
Language
Document type
704
297
290
82
77
22
21
11
9
6
3
1
Countries
69
66
60
52
49
40
38
37
34
30
27
26
26
25
23
19
18
18
17
17
16
15
12
12
11
11
11
10
10
9
8
8
8
7
6
6
6
6
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
697
107
78
69
40
34
14
2
Toolboxes
175
166
117
83
71
46
37
32
32
23
22
21
21
19
19
14
11
9
7
7
6
6
4
4
1
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Southern Med Review (2009)2;1:2-6
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Bull World Health Organ 2017;95:594–598
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
ПАКЕТ МЕР ПО РЕАЛИЗАЦИИ ПОЛИТИКИ В ОТНОШЕНИИ ВНЕДРЕНИЯ НОВЫХ ПРОТИВОТУБЕРКУЛЕЗНЫХ ПРЕПАРАТОВ
Report of a mission 20–24 April 2015
